Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$148.66
+0.1%		$135.97
$108.35
▼
$160.27
$41.95B1.251.77 million shs1.80 million shs
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$279.60
-2.5%		$228.65
$144.26
▼
$289.60
$13.37B1.38955,716 shs703,679 shs
Icon Plc stock logo
ICLR
Icon
$167.05
-1.4%		$163.15
$66.57
▼
$203.91
$12.49B1.21858,684 shs556,623 shs
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$240.25
-0.4%		$208.88
$154.50
▼
$251.36
$38.95B1.181.48 million shs1.10 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
+0.00%-0.44%+13.18%+30.81%+25.51%
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
-2.39%-0.75%+24.71%+78.97%+77.79%
Icon Plc stock logo
ICLR
Icon
-1.42%+0.89%-1.74%+45.15%-6.45%
IQVIA Holdings Inc. stock logo
IQV
IQVIA
-0.35%-1.57%+16.48%+40.11%+24.75%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$148.66
+0.1%		$135.97
$108.35
▼
$160.27
$41.95B1.251.77 million shs1.80 million shs
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$279.60
-2.5%		$228.65
$144.26
▼
$289.60
$13.37B1.38955,716 shs703,679 shs
Icon Plc stock logo
ICLR
Icon
$167.05
-1.4%		$163.15
$66.57
▼
$203.91
$12.49B1.21858,684 shs556,623 shs
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$240.25
-0.4%		$208.88
$154.50
▼
$251.36
$38.95B1.181.48 million shs1.10 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
+0.00%-0.44%+13.18%+30.81%+25.51%
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
-2.39%-0.75%+24.71%+78.97%+77.79%
Icon Plc stock logo
ICLR
Icon
-1.42%+0.89%-1.74%+45.15%-6.45%
IQVIA Holdings Inc. stock logo
IQV
IQVIA
-0.35%-1.57%+16.48%+40.11%+24.75%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2.89
Moderate Buy$160.247.79% Upside
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
2.69
Moderate Buy$255.65-8.57% Downside
Icon Plc stock logo
ICLR
Icon
2.41
Hold$170.402.01% Upside
IQVIA Holdings Inc. stock logo
IQV
IQVIA
2.88
Moderate Buy$241.880.68% Upside

Current Analyst Ratings Breakdown

Latest ICLR, CRL, IQV, and A Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$160.00 ➝ $175.00
8/10/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$235.00 ➝ $300.00
8/10/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$300.00
8/10/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$264.00
8/7/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$260.00 ➝ $300.00
8/6/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$291.00
8/6/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$215.00 ➝ $282.00
8/6/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeNeutral ➝ Overweight$180.00 ➝ $310.00
8/5/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$300.00
8/5/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Evercore Inc logo
Evercore
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform
7/31/2026
Icon Plc stock logo
ICLR
Icon
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$194.00
(Data available from 8/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$6.95B6.04$6.64 per share22.40$23.78 per share6.25
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$4.02B3.32$21.91 per share12.76$64.39 per share4.34
Icon Plc stock logo
ICLR
Icon
$8.25B1.55$17.26 per share9.68$120.07 per share1.39
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$16.31B2.42$18.15 per share13.24$38.93 per share6.17
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.30B$4.9829.8522.462.6319.55%24.33%12.99%8/26/2026 (Estimated)
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
-$144.34M-$4.85N/A22.282.90-5.96%15.75%6.51%11/4/2026 (Estimated)
Icon Plc stock logo
ICLR
Icon
$229.34M$4.2639.2115.446.763.99%8.02%4.56%10/28/2026 (Estimated)
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$1.36B$8.0629.8118.622.018.10%30.25%6.54%10/27/2026 (Estimated)

Latest ICLR, CRL, IQV, and A Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/26/2026Q3 2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.49N/AN/AN/A$1.84 billionN/A
8/5/2026Q2 2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$2.77$3.02+$0.25-$0.03$980.53 million$1.00 billion
7/30/2026Q1 2026
Icon Plc stock logo
ICLR
Icon
$2.55$2.56+$0.01$0.94$2.00 billion$2.06 billion
7/28/2026Q2 2026
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$3.03$3.15+$0.12$1.53$4.30 billion$4.37 billion
5/27/2026Q2 2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.41$1.49+$0.08$1.20$1.80 billion$1.84 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.020.69%+6.58%20.48%9 Years
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
N/AN/AN/AN/AN/A
Icon Plc stock logo
ICLR
Icon
N/AN/AN/AN/AN/A
IQVIA Holdings Inc. stock logo
IQV
IQVIA
N/AN/AN/AN/AN/A

Latest ICLR, CRL, IQV, and A Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/20/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
quarterly$0.25500.77%6/30/20266/30/20267/22/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.43
2.10
1.62
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
0.92
1.35
1.04
Icon Plc stock logo
ICLR
Icon
0.23
0.95
0.95
IQVIA Holdings Inc. stock logo
IQV
IQVIA
2.18
0.71
0.71

Institutional Ownership

CompanyInstitutional Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
98.91%
Icon Plc stock logo
ICLR
Icon
95.61%
IQVIA Holdings Inc. stock logo
IQV
IQVIA
89.62%

Insider Ownership

CompanyInsider Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
1.30%
Icon Plc stock logo
ICLR
Icon
44.00%
IQVIA Holdings Inc. stock logo
IQV
IQVIA
1.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
18,100282.43 millionN/AOptionable
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
19,70047.74 million47.12 millionOptionable
Icon Plc stock logo
ICLR
Icon
40,10076.57 million42.88 millionOptionable
IQVIA Holdings Inc. stock logo
IQV
IQVIA
93,000164.60 million161.80 millionOptionable

Recent News About These Companies

Pallas Capital Advisors LLC Acquires New Shares in IQVIA Holdings Inc. $IQV
August 18 at 6:08 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-pallas-capital-advisors-llc-acquires-new-shares-in-iqvia-holdings-inc-iqv-2026-08-18/
Plato Investment Management Ltd Invests $1.34 Million in IQVIA Holdings Inc. $IQV
August 18 at 5:36 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-plato-investment-management-ltd-invests-134-million-in-iqvia-holdings-inc-iqv-2026-08-18/
Global Retirement Partners LLC Purchases Shares of 7,179 IQVIA Holdings Inc. $IQV
August 18 at 4:00 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-global-retirement-partners-llc-purchases-shares-of-7179-iqvia-holdings-inc-iqv-2026-08-18/
IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group
August 17 at 11:13 PM  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/08/17/10431404.htm
10,831 Shares in IQVIA Holdings Inc. $IQV Purchased by OneDigital Investment Advisors LLC
August 17 at 6:31 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-10831-shares-in-iqvia-holdings-inc-iqv-purchased-by-onedigital-investment-advisors-llc-2026-08-17/
Nippon Life Global Investors Americas Inc. Purchases Shares of 4,300 IQVIA Holdings Inc. $IQV
August 17 at 5:51 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-nippon-life-global-investors-americas-inc-purchases-shares-of-4300-iqvia-holdings-inc-iqv-2026-08-17/
Focus Partners Advisor Solutions LLC Acquires New Shares in IQVIA Holdings Inc. $IQV
August 17 at 4:00 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-focus-partners-advisor-solutions-llc-acquires-new-shares-in-iqvia-holdings-inc-iqv-2026-08-17/
SFE Investment Counsel Invests $11.41 Million in IQVIA Holdings Inc. $IQV
August 16 at 6:23 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-sfe-investment-counsel-invests-1141-million-in-iqvia-holdings-inc-iqv-2026-08-16/
These were the Triangle's highest-paid CEOs in 2025
August 14, 2026  |  msn.comhttps://www.msn.com/en-us/money/economy/these-were-the-triangle-s-highest-paid-ceos-in-2025/ar-AA2a6DqY
Manager sues IQVIA, alleges firing over Indian cultural conversations at work
August 13, 2026  |  hcamag.comH
Adaptive Biotechnologies (NASDAQ:ADPT) versus IQVIA (NYSE:IQV) Financial Review
August 13, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30958777
IQV Stock Gains 42% in 3 Months: Here's What You Should Know
August 12, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2973533/iqv-stock-gains-42-in-3-months-here-s-what-you-should-know?cid=cs-stocknewsapi-ft-analyst_blog|price_surge_/_plunge-2973533
NewEdge Advisors LLC Increases Stock Holdings in IQVIA Holdings Inc. $IQV
August 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-newedge-advisors-llc-increases-stock-holdings-in-iqvia-holdings-inc-iqv-2026-08-11/
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term
August 10, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2971839/why-iqvia-holdings-iqv-is-a-top-value-stock-for-the-long-term?cid=cs-stocknewsapi-ft-fundamental_analysis|zacks_education_value_score-2971839
How Investors Are Reacting To IQVIA Holdings (IQV) Cardiac Gene Therapy Push And Higher 2026 Revenue Outlook
August 9, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/investors-reacting-iqvia-holdings-iqv-151122324.html
Oliver Luxxe Assets LLC Acquires Shares of 18,573 IQVIA Holdings Inc. $IQV
August 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-oliver-luxxe-assets-llc-acquires-shares-of-18573-iqvia-holdings-inc-iqv-2026-08-09/
Legacy Wealth Management LLC MS Sells 8,935 Shares of IQVIA Holdings Inc. $IQV
August 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-legacy-wealth-management-llc-ms-sells-8935-shares-of-iqvia-holdings-inc-iqv-2026-08-09/
Community Trust & Investment Co. Increases Position in IQVIA Holdings Inc. $IQV
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-community-trust-investment-co-increases-position-in-iqvia-holdings-inc-iqv-2026-08-08/
Assenagon Asset Management S.A. Purchases 109,284 Shares of IQVIA Holdings Inc. $IQV
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-assenagon-asset-management-sa-purchases-109284-shares-of-iqvia-holdings-inc-iqv-2026-08-08/
IQVIA Holdings (IQV) is a Top-Ranked Momentum Stock: Should You Buy?
August 7, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2970979/iqvia-holdings-iqv-is-a-top-ranked-momentum-stock-should-you-buy?cid=cs-stocknewsapi-ft-fundamental_analysis|zacks_education_momentum_score-2970979
Balefire LLC Sells 12,141 Shares of IQVIA Holdings Inc. $IQV
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-balefire-llc-sells-12141-shares-of-iqvia-holdings-inc-iqv-2026-08-07/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
SpaceX logo beside a rocket on a launch pad at sunset, with a colorful sky in the background.
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
By Jeffrey Neal Johnson | August 3, 2026
SK hynix logo above a robotic arm placing memory chips on a wafer in a server data center.
Why SK hynix Could Be the Best AI Chip Stock to Buy Now
By Thomas Hughes | July 29, 2026
Data center at night with a labeled AI Compute Unit server rack and a technician working nearby.
5 AI Stocks Are Pulling Back—Which Growth Catalysts Still Look Strongest?
By Thomas Hughes | July 28, 2026
Broadcom logo on a silicon wafer with circuit boards, fiber optic cables, and a network switch in a data center.
Broadcom May Be the Biggest Winner From Alphabet's Earnings
By Leo Miller | July 26, 2026
General Electric (GE) logo displayed on glass panel with wind turbines and solar panels in the background.
GE Vernova’s AI Power Boom Faces a Profit Test
By Peter Frank | August 12, 2026
Agilent Technologies stock logo

Agilent Technologies NYSE:A

$148.66 +0.21 (+0.14%)
Closing price 08/18/2026 03:59 PM Eastern
Extended Trading
$146.41 -2.25 (-1.51%)
As of 08/18/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Charles River Laboratories International stock logo

Charles River Laboratories International NYSE:CRL

$279.60 -7.04 (-2.46%)
Closing price 08/18/2026 03:59 PM Eastern
Extended Trading
$277.67 -1.93 (-0.69%)
As of 08/18/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Icon stock logo

Icon NASDAQ:ICLR

$167.05 -2.40 (-1.42%)
Closing price 08/18/2026 04:00 PM Eastern
Extended Trading
$167.12 +0.07 (+0.04%)
As of 08/18/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

IQVIA stock logo

IQVIA NYSE:IQV

$240.25 -0.99 (-0.41%)
Closing price 08/18/2026 03:59 PM Eastern
Extended Trading
$240.06 -0.19 (-0.08%)
As of 08/18/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas